StockData
Integrated BioPharma Inc logo

Integrated BioPharma Inc (INBP) stock

INBPOTCPharmaceutical PreparationsFiscal year ends June 30
Financials through Q4 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$0.18+0.00 (0.00%)

Close on Oct 19, 2026Market cap $5.59MP/E –Yield –

Integrated BioPharma price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Integrated BioPharma's price to book ratio was 0.3× on Oct 19, 2026, against 0.5× a year earlier. Over the last 5 years it ranged from 0.3× to 453.1×, with a median of 0.5×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 20260.3×−0.2
2025Dec 31, 20250.5×+0.0
2024Dec 31, 20240.5×+0.1
2023Dec 29, 20230.4×−0.2
2022Dec 30, 20220.6×−1.5
2021Dec 31, 20212.1×−1.0
2020Dec 31, 20203.1×−0.2
2019Dec 31, 20193.3×−19.1
2018Dec 31, 201822.5×–

More Integrated BioPharma figures

See a number that looks wrong?